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anletha dose(LD5) fordisl was simated tobeappimaty28glkg,Tesemicedeveloped
inflammatorylesions ofthelung and lv aswel as liver cel necrosis with elvated serum levels of
aanine am ino se, a tea . andla1c aciddehydroge .Admin on
ofCS-D4alonealop cedlehlityinthemicewith anLD of6-7 lg. CS-D4-tted e
also exhibiedp y and hepatic lesions and eevated serum enzymes. Analysi ofLDW data
indica that CS-D4 is about as toxc as arbon aetr oride or triloethye. We mesured
y l rical fmation inCS-D4-teated mice and od incases ofappro e 20-fold in
ie and ap nat 7-fold in lung on day 4 follwing injecton. Our findings are sificant
because in viro emen a demo thatCSs canmigat outofbreastimplant, andin
oeeperimeats CSshavebeen sh to bewidelyditibuted inmanyorgs after asinglesub-
cutaneous injtion and topeist for at least ayear. KeywurdL breastimplnts, cydosioxmesi sili-
cone,toxilogy. EnvionHeAkb PhPspt107:161-165 (1999). [Online 14January 19991
b:/lehpnatl.niehs.nib.g v/d/l1999/107p16165ebe nlnabsact/h*nl
It has been estimated that at least 800,000
and perhaps as many as 2 million women
have had silicone breast implants in the
United States (1-3). In the past decade
there has been widespread interest in the
potential risk from exposure to the silicone
present in these implants. In spite of the
fact that many investigations have been
undertaken, much remains to be learned
about silicone biology. Implants are com-
posed primarily of high molecular weight
silicone polymers (polydimethylsiloxane)
(4), but 1-2% of the contents of implants
are low molecular weight silicones includ-
ing cyclosioxanes (CSs). These compounds
are cyclic oligomers (n = 3-20) ofdimethyl-
siloxane (e.g., Fig. lA) and can migrate out
of intact implants (5-7). In addition, it is
known that implants may rupture and
release their contents (8,9). We have recent-
ly shown that after a single subcutaneous
injection of breast implant distillate [con-
taining hexamethylcyclotrisiloxane (CS-
D3), octamethylcyclotetrasiloxane (CS-
D4), decamethylcyclopentasiloxane (CS-
D5), and dodecamethylcyclohexasiloxane
(CS-D6)], CSs were widely distributed
throughout the body (10). These com-
pounds were found in all of the 10 organs
we examined and persisted for at least 1
year in them and in' abdominal fat.
In addition to possible exposure from
breast implants, other medical procedures
may also expose patients to CSs. Low mole-
cular weight siloxanes, induding CSs, have
been used in ophthalmology to treat retinal
detachment (11). In spinal surgery, the use
of soft silicone gels has the potential to
expose patients to CSs (12). Also, in the
past in cosmetic surgery, low molecular
weight silicone oils containing CSs were
used to remove wrinkles (13).
Such studies raise the question of
whether CSs are toxic. Previously, most
investigations have focused on high molec-
ular weight silicone polymers (polydi-
methylsiloxane) (1416); however, unless
there is rupture ofthe implant, exposure to
the polymer is unlikely. On the other
hand, even without rupture, the transmi-
gration oflow molecular weight CSs from
intact implants (5-7) indicates that many
and perhaps all organs have the potential
for exposure to these compounds (10). To
examine the possible role of CSs in tissue
injury, we undertook a series of experi-
ments in which we administered breast
implant distillate (containing CS-D3, CS-
D4, CS-D5, and CS-D6) or CS-D4 alone
to female mice. Our findings indicate that
these compounds are highly toxic and pro-
duce extensive tissue injury and death in
these mice.
Materials and Methods
Breast implants used in this study were
explanted breast implants obtained after sur-
gical removal from patients. Breast implant
distillate was prepared from these implants
as previously described (5,17). Gas chro-
matography/mass spectrometric (GC/MS)
analysis revealed that the distillate consisted
of a mixture of CS-D3 (18%), CS-D4
(60%), CS-D5 (20%), and CS-D6 (2%),
with less than 1% low-molecular-weight lin-
earsioxanes (Fig. 1B). Thedistillate also con-
tained platinum (40 pg/kg distillate) as
revealed by inductively coupled plasma mass
spectroscopy (ICP/MS) (5). CS-D4 (Fig. lA)
was purchased from Ohio Valley Specialty
Chemical (Marietta, OH) and was found to
be more than 99% pure by CC/MS (and Pt-
free); 2,3- and 2,5-dihydroxybenzoic acid
(DHBA) were purchased from Sigma (St.
Louis, MO). Al the reagents and chemicals
usedwere ofanalytical grade.
Exposure ofmice to cyclosilxanes. All ani-
mal use procedures were in strict accordance
with the NIH Guidefor the Care and Use of
LaboratoryAnimals and were approved by the
Baylor Animal Care Committee. For median
lethal dose (LD50) studies, groups (5-12
mice/group) of female CD-1 mice (8-10
weeks of age; 25-30 g body weight) were
injected intraperitoneally with 1 ml soy oil
(controls, -32 g/kg), 0.1-1.0 ml (3.5-35 g/kg)
breast implant distillate, or CS-D4. This
dosage regimen was repeated with separate
groups ofmice for histological and biochemi-
cal studies. Soy oil-treated mice served as con-
trols throughout these experiments. Food and
water were provided ad libitum. For LD50
studies, mice were followed for 14 days. Mice
that were clearly moribund were sacrificed.
Results were tallied as number died per num-
ber injected. At 14 days, survivors were sacri-
ficed by CO2 narcosis followed by cervical dis-
location. For histopathology and biochemical
studies, separate groups of mice (4-6/group)
were injected with distillate or CS-D4 and
were sacrificed at 4 or 14 days. Blood samples
collected from the rear orbital sinus of these
mice were used to measure aspartate amino-
transferase (AST), alanine aminotransferase
(ALT), and lactic acid dehydrogenase (LDH)
levels. For the hydroxyl radical measurement
studies, separategroups ofmice (4/group) were
injected with 8.75 g/kg CS-D4 or soy oil and
sacrificed at 1 or 4 days after treatment to
determine the 2,3-DHBA formation in liver
andlungtissues.
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Figure 1. The structure of octamethylcyclote-
trasiloxane (CS-D4) and proportions of cyclosilox-
anes (CSs) in breast implant distillate. (A)
Molecular structure ofCS-D4. (B) Gas chromatog-
raphy/mass spectrometric analysis of breast
implant distillate (90 ng). Abbreviations: CS-D3,
hexamethylcyclotrisiloxane; CS-05, decamethyl-
cyclopentasiloxane; CS-D6, dodecamethylcyclo-
hexasiloxane. We used Wiley library mass spec-
tral data to confirm the presence of individual
CSs. The relative proportion of each compound
was approximately 18, 60, 20, and 2% for CS-D3,
CS-D4, CS-D5, and CS-D6, respectively.
Table 1. Mortality after administration of breast
implant distillate or octamethylcyclotetrasiloxane
(CS-D4)
Agent 3.5a 8.75 17.5 26.25 35
Distillate 015b 0/5 1/5 3/12 5/5
CS-D4 0/6 416 5/5 ND 6/6
ND,notdetermined.
Dose in grams perkilogram administered intraperitoneallyto
female mice.
hNumber dead pernumber injected by 14days.
Histopathological studies. Complete
autopsies were performed; organs were
fixed in 10% buffered formalin, embedded,
cut, and stained with hematoxylin and
eosin for light microscopy. Lungs were
inflated with the same fixative until they
were fully expanded and fixed for at least
12 hr. Toprovide asemiquantitative assess-
ment of tissue damage 4 days after treat-
ment, we graded all sections oflung and
liver and assigned a score to each section.
Lesions were graded 0-4, with 0 represent-
ing no change and 4 representing severe
changes. For lung, we evaluated interstitial
inflammation, intraalveolar inflammation,
edema, and focal hemmorhage. For liver,
we evaluated extensive necrosis, individual
cell necrosis, inflammation, microvesicular
(hepatocyte) steatosis, mitosis, and apopto-
sis. Slides were read without knowledge of
the treatment group (blindly).
Hydroxyl radical measurements by
HPLC Hydroxyl radical formation was mea-
sured by trapping the radical as 2,3-DHBA
after administration ofsalicylic acid (100
mg/kgip 1 hrbeforesacrifice) (18). Liverand
Figure Histopathological changes in lung and liver of mice treated with breast implant distillate. (A)
Section oflung from a mouse sacrificed 14days after exposure to 0.5 ml (17.5g/kg) breastimplantdistillate.
There is thickening of the alveolar septae as a result of an inflammatory cell infiltrate, including lympho-
cytes and polymorphonuclear leukocytes. This and subsequent sections were stained with hematoxylin
and eosin and photographed at 200x. (B) Section of liverfrom the same mouse shown in (A). Note individ-
ual cell necrosis (large arrows), mitotic figure (small arrow) and Kupffer cell hyperplasia. (C) Section of
lung from a mouse sacrificed 4 days after exposure to 0.5 ml (17.5 g/kg) breastimplantdistillate. Note inter-
stitial inflammation. A bronchiole containing eosinophilic proteinaceous material (edema) is present, and
the parenchyma shows intraalveolar inflammatory cells. (D) Section ofliverfromthe same mouse shown in
(C). Individual cell necrosis, apoptotic bodies, and an acute inflammatory response are present
lungtissues from soyoil-treated (control) and
CS-D4-treated animals (8.75 g/lkg) were col-
lected at 1 day and 4 days for the quantita-
tion of2,3-DHBA. This hydroxyl adduct of
salicylate is routinely used for quantification
ofhydroxyl radicals in vivo (18). Liver and
lung tissues were homogenized in 0.25 M
perchloric acid (PCA) containing 100 pM
EDTA and 100 pM sodium metabisulfite.
The acid soluble extracts (supernatants
obtained by centrifiigation at 10,000 rpm)
were filtered though 0.2-pm filters, and the
filtrate was analyzed for DHBA formation
using HPLC/EC detection. DHBAs were
separated on a reverse-phase column
(DHBA-250, 250 x 3 mm, 5-pm partide
size; ESA, Inc., Chelmsford, MA) using an
isocratic mobile phase containing 50 mM
sodium acetate, 50 mM citric acid, 8%
methanol, and 2% isopropyl alcohol (adjust-
ed to pH 2.5 with phosphoric acid). The
flow rate was set at0.5 ml/min andtheoxida-
tion of DHBAs was studied at 250 mV.
Oxidation ofsalicylate was measured at 800
mV using a Coularay dectrochemical detec-
tor (ESA). Results were normalized to thesal-
icylate levels in the tissues and are expressed
as the ratio of2,-DHBA to salicylate. Forall
ofthe above determinations, we performed
two-tailed t-tests ofvalues for treated mice
versusthosefor soyoilcontrols.
SerumAST,ALT, and LDH levels were
analyzed by a Vitros 950 chemical analyzer
(Johnson &Johnson, St. Louis, MO).
Results
We exposed groups offemale mice to differ-
ent doses of distillate (3.5-35 glkg) and
found that all ofthe mice which received 35
g/kg distillate died in 5-8 days; 25% ofthe
mice that received 26 g/kg distillate and
20% ofthe micethat received 17.5 g/kgdis-
tillate also died in this timeperiod (Table 1).
These experiments demonstrated that some
or all ofthe components ofthe distillate are
lethal with an LD50 for the distillate of -28
g/kg (Table 1). Histopathology on tissues
obtained from mice surviving to 14 days
revealed lung, liver, and peritoneal changes.
Lungs showed interstitial inflammation con-
sisting of lymphocytes and neutrophils,
edema, and thromboemboli in small to mid-
size vessels. Some of these changes are
shown in Figure 2A. In the liver, we
observed individual hepatocyte necrosis,
areas ofregenerating hepatocytes, giant cells,
dusters ofproliferating oval orbile duct cells,
Kupffer cell proliferation, and neutrophils
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Table 2. Histopathological changes in liver and lung of mice treated with breastimplantdistillate
Liver Lung
Dose Extensive Individual Interstitial lntraalveolar Focal
(g/kg) necrosis cell necrosis Inflammation Steatosis Mitosis Apoptosis inflammation inflammation Edema hemorrhage
0 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6
3.5 3/6(+) 1/6(+) 5/6(+) 0/6 3/6(+ 0/6 5/6(+) 3/6(+) 2/6(+ 0/6
8.75 1/6(+) 4/6(+) 3/6(++) 1/6(+) 0/6 3/6(+) 6/6(++) 4/6(+) 0/6 2/6(+
17.5 216 (++) 4/6(+) 6/6(+) 0/6 0/6 2V6(+) 6/6(++) 5/6(+) 0/6 0/6
35 1/6(+) 5/6(++) 4/6(+ 2/6(+) 116(+ 2/6(+) 516(+++) 4/6(++) 3/6(+) 3/6(++)
Values shown are numbers ofmice with damage per number injected. The 0-dose group received 1 ml soy oil (-32 g/kg). Average grade of lesion: +, mild; ++, moderate; +++, moderately
severe.
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Figure 3. Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and lactic acid dehydrogenase (LDH) enzyme activities after exposure to breast
implant distillate and octamethylcyclotetrasiloxane (CS-D4). (A) Enzyme activities in serum obtained from mice 4 days after treatment with breast implant distillate
(see 'Materials and Methods"). For all enzyme determinatons at all doses, values were significantly differentfrom soy oil-treated mice (p<0.04). (B) Enzyme activi-
ties in serum obtained from mice 4 days after treatmentwith CS-D4. For all enzyme determinations at all doses, values were significantly differentfrom soy oil-treat-
ed mice (p<0.001). Soyoil-treated mice values for enzymes obtained from two groups of controls (five control micefor distillate and five control mice for CS-D4; n=10)
were averaged and are presented as control values. Values for soy oil-treated controls were as follows: ALT, 50.9 ± 5.95 IU/I; AST, 131.3 ± 27.5 IU/I; and LDH, 1,743 ±
457 lU/I. Fourto six mice were used forthe determination of enzyme activityfordistillate or CS-D4-treated mice. Values are presented asthe mean ± standard error.
predominantly around the central veins
(Fig. 2B). Peritoneal surfaces were covered
by acute and organizing inflammatory exu-
date (not shown). The severity of the
changes increased with dose. No other
pathologic changes were observed.
Intraperitoneal injection of soy oil caused
mild, focal, acute inflammation on the peri-
toneal surface of the liver and adjacent
superficial parenchyma (notshown).
To examine more acute changes, we
administered distillate (3.5-35 g/kg) to mice
and sacrificed them at 4 days. In the lungs
we found interstitial hypercellularity consist-
ing primarily of neutrophils; intraalveolar
macrophages, neutrophils, and lymphocytes;
edema; and focal hemorrhage; occasionally
we found vessels with thromboemboli (Fig.
2C). In the liver we found extensive inflam-
matory and necrotic changes. Figure 2D
illustrates necrosis of individual liver cells
and bile stasis. The histopathologic changes
with dose are summarized in Table 2. Other
markers of severe liver damage such as
bilestasis and hepatocyte degeneration are
seen only at high doses (data not shown).
These data demonstrate that, in general,
there is an increase both in the number of
mice with individual changes and in the
severity of these changes as the dose is
increased. Taken together with the 14-day
findings, the changes observed at 4 days in
lung and liver represent a pattern of devel-
opingdamage, regeneration, and repair. The
peritoneal surfaces showed a dense acute
inflammatory infiltrate that was also present
on the serosal surface ofabdominal organs.
These changes increased in severity as a
function ofdose. No pathologic changes in
other organs were observed. Serum ALT
and AST rose sharply with dose; these
enzymes are used clinically as markers of
liver injury (Fig. 3A). LDH also rose with
dose and is a nonspecific marker of tissue
injury (Fig. 3A).
Because CS-D4 is the most abundant
cyclosiloxane in breast implant distillate
(see "Materials and Methods"), we admin-
istered CS-D4 alone to mice and found
that it was lethal (Table 1). Mice died in
5-8 days with an LD50 of6-7 g/kg (Table
1). Histopathology at 14 days on mice sur-
viving CS-D4 treatment (3.5 and 8.75
g/kg) revealed changes similar to those seen
with the distillate (not shown), but at the
same dose, changes in CS-D4-treated mice
tended to be more severe.
In a separate experiment, we evaluated
acute tissue injury and serum enzyme levels
after CS-D4 injection. Four days after injec-
tion we found severe pulmonary andhepatic
lesions similar to those seen after injection of
the distillate. These changes are summarized
in Table 3, and reveal increasing damage as
a function ofdose. Injection ofCS-D4 also
resulted in large increases in serum enzymes
(Fig. 3B). For example, in mice receiving
8.75 g/kg bw (slightly more than the LD50)
at 4 days, ALT, AST, and LDH values rose
15-, 6-, and 4-fold, respectively. It is also of
interest that with CS-D4 mice, doses as low
as 3.5 g/kg produced statistically significant
(p<O.OOl) elevations in serum enzymes.
As a marker of free radical activity we
measured hydoxyl radical formation in liver
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Table3. Histopathological changes in liver and lung of micetreated with octamethylcyclotetrasiloxane (CS-D4)
Liver Lung
Dose Extensive Individual Interstitial lntraalveolar Focal
(g/kg) necrosis cell necrosis Inflammation Steatosis Mitosis Apoptosis inflammation inflammation Edema hemorrhage
0 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6
3.5 0/5 1/5 (++) 2/5(+) 1/5(+) 25(++) 0/5 5/5(++) 25(++) 0/5 0/5
8.75 1/5(+) 3/5(++) 4/5(+) 25(++) 1/5(+++) 3/5(+) 5/5(+++) 4/5 (+) 1/5(+) 1/5(+)
17.5 0/5 3/5(+) 45 1/5+) 1/5(++) 3/5(++) 5/5(++) 3/5(++) 1/5(++) 1/5(++)
35 0/4 4/4(++) 4/4(++) 2/4(+) 1/4(+) 1/4(+) 4/4(+++) 4/4(++) 24(++) 24(+)
Valuesshown are numbersofmicewith damage pernumberinjected.The0-dosegroup received 1 ml soyoil(-32g/kg).Average gradeoflesion:+,mild;++,moderate;+++,moderatelysevere.
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Figure 4. Hydroxyl radical formation in lung and
liver of mice exposed to octamethylcyclote-
trasiloxane (CS-D4). Values are expressed as the
ratio of 2,3-dihydroxybenzoic acid (DHBA) to sali-
cylate. Each value represents the mean ± stan-
dard error of data obtained from four individual
mice. *p<03j001 as compared to control mice.
and lung of control (soy oil-injected) and
CS-D4-injected (8.75 glkg) mice by salicys-
late trapping (see "Materials and Methods").
Onday 1, no increase inhydroxyl radical for-
mation in either liver orlung was noted (Fig.
4). Byday 4 there was a dramatic increase in
radical formation with an -20-fold increase
in liver and an ~7-fold increase in lung (Fig.
4). These data indicate that large increases in
hydoxyl radical formation occur well in
advance ofdeath.
Discussion
Our data provide evidence that CSs found
in breast implants produce significant tissue
injury and death when administered to
female CD-i mice. To the best of our
knowledge, this is the first study demon-
strating the in vivo toxicity of CSs.
Injection of the distillate resulted in liver
and lung damage and death in 5-8 days.
Histopathologic evidence of damage was
seen in mice that received low doses ofdis-
tillate and survived 14 days and in mice that
were sacrificed at 4 days (Fig. 2, Table 2).
Markedly elevated serum enzyme values
also documented tissue injury by breast
implant distillate (Fig. 3A). In view of the
extensive changes in both liver and lung, it
is likely that both hepatic failure and respi-
ratory insufficiency contributed to the
death ofthese mice.
All of these effects were mimicked by
administration ofCS-D4, which comprises
-60% ofthe distillate. Even low, nonlethal
doses ofCS-D4 (3.5 g/kg) produced signifi-
cant tissue injury, as documented by
histopathologic changes in liver and lung
(Table 3) and elevated serum enzymes (Fig.
3B). The rise in enzyme levels at the 35-
g/kg dose was less pronounced than that
seen with the 17.5-glkg dose. At present we
have no explanation for this observation.
We estimated the LD50 ofCS-D4 to be
-6-7 g/kg. CS-D4 appears to be more
toxic on a gram per kilogram basis than the
distillate, even when the composition of
the distillate (60% CS-D4) is taken into
account. The reason for this apparent dif-
ference is undear; however, most chemicals
show a range of toxicity (see below), and
the discrepancy is not large. Also, at pre-
sent we do not know if other CSs in the
distillate are toxic or may even be protec-
tive against the effects ofCS-D4. This vari-
ability extends to the histopathology and
enzyme findings and is probably accounted
for by the variability seen in most animal
experiments. The LD50 value of CS-D4 is
in the same range for rodent LD50s (oral)
ofwell-studied toxic organic solvents such
as CC14 (2.3-8.3 g/kg), trichloroethylene
(2.4-5.7 g/kg), and hexachloroethane (4.5
g/kg) (19-22). Given some variation of
LD50 values resulting from differences in
species, strain, sex, and routes of adminis-
tration, the value for CS-D4 indicates that
this compound exhibits toxicity compara-
ble to these other agents.
We also found dramatic increases in
hydroxyl radical formation in the liver and
lungs of CS-D4-treated mice (Fig. 4) by
day 4, a time at which extensive inflamma-
tory lesions were present. It is likely that
these increases in free radicals result from
the activity of both parenchymal and
inflammatory cells. Organic solvents are also
known to cause free radical tissue damage
(11,12). For example, free radicals are a
major factor in liver injury produced by
another hepatic toxin, CC14 (23, 24).
Cojocel et al. (25) also suggested that free
radicals play a role in the nephrotoxicity of
trichloroethylene. The role offree radicals in
tissue injury and death produced by CS-D4
cannot be gauged completely, but such large
increases probably contribute to the toxicity
ofCS-D4. Although we have measured only
hydroxyl radical formation, it is likely that
other free radicals such as the superoxide,
peroxyradicals, and nitric oxide radicals are
produced aswell (26).
Our data demonstrate that a mixture of
low-molecular-weight CSs contained in
breast implants is highly toxic and that at
least one specific compound, CS-D4, is
toxic as well. The CSs have been considered
inert, but there are data indicating that
when silicone oils containing CSs are inject-
ed intraocularly, they produce local toxic
effect (11). We have no evidence that these
compounds are metabolized, but it is dear
that they evoke strong biological responses.
It remains to be determined ifother CSs or
the platinum found in implants produces
tissue injury or death (5). Further, ourstud-
ies have not evaluated possible long-term
effects of CSs such as chronic inflamma-
tion, chronic pulmonary and liver disease,
or neoplasia. Nevertheless, our results
underscore the importance of a complete
analysis ofthe toxicityofCSs.
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